Zealand Pharma
Employee Participants0
Total Rating0
Revenue$0
Developer of novel peptide medicines and possesses created to focus on metabolic diseases and acute care indications. The company's novel peptide medicines and possesses focus on developing peptide based drugs for the treatment of diabetes, ventricular arrhythmia and other health issues enabling patients avail advanced proprietary pipeline of novel medicines. Read More
Headquarters Smedeland 36, Copenhagen, 2600, DNK
Website www.zealandpharma.com
0/100